Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DBV Technologies S.A. - American Depositary Shares (NQ:DBVT)

19.09 UNCHANGED

Streaming Delayed Price Updated: 4:15 PM EDT, Mar 20, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	3
Open	19.09
Bid (Size)	19.14 (600)
Ask (Size)	19.40 (3,000)
Prev. Close	19.09
Today's Range	19.09 - 19.09
52wk Range	3.910 - 26.18
Shares Outstanding	55,096,537
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

DBV Technologies to Participate in Upcoming March Investor Conferences

March 04, 2026

From DBV Technologies S.A.

Via GlobeNewswire

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026

March 03, 2026

From DBV Technologies S.A.

Via GlobeNewswire

Performance

YTD	+0.2%	+0.2%
1 Month	-11.0%	-11.0%
3 Month	-5.8%	-5.8%
6 Month	+100.9%	+100.9%
1 Year	+328.0%	+328.0%

More News

DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting

February 28, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting

February 10, 2026

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit

February 09, 2026

From DBV Technologies S.A.

Via GlobeNewswire

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026

February 05, 2026

From DBV Technologies S.A.

Via GlobeNewswire

GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics

January 20, 2026

Via MarketMinute

DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing

January 16, 2026

From DBV Technologies S.A.

Via GlobeNewswire

Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025

January 12, 2026

From DBV Technologies S.A.

Via GlobeNewswire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

January 07, 2026

From DBV Technologies S.A.

Via GlobeNewswire

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025

January 05, 2026

From DBV Technologies S.A.

Via GlobeNewswire

Which stocks are moving before the opening bell on Monday? ↗

December 22, 2025

Via Chartmill

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

December 17, 2025

Via Chartmill

These stocks are gapping in today's session ↗

December 17, 2025

Via Chartmill

What's going on in today's pre-market session ↗

December 17, 2025

Via Chartmill

DBV Technologies Stock Soars 63% After Hours As Strong Results For Peanut Allergy Patch Clears Path For FDA Filing ↗

December 16, 2025

Via Stocktwits

DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years

December 16, 2025

From DBV Technologies S.A.

Via GlobeNewswire

These stocks have an unusual volume in today's session ↗

December 03, 2025

Via Chartmill

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025

December 02, 2025

From DBV Technologies S.A.

Via GlobeNewswire

RFK Jr Rejects Early Exposure Theory On Rising Peanut Allergies, Says Aluminum-Based Vaccines Are The Reason ↗

November 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 12, 2025

Via Benzinga

Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket ↗

November 12, 2025

Via Benzinga

DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years

November 11, 2025

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

November 04, 2025

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer

November 03, 2025

From DBV Technologies S.A.

Via GlobeNewswire

Frequently Asked Questions

Is DBV Technologies S.A. - American Depositary Shares publicly traded?

Yes, DBV Technologies S.A. - American Depositary Shares is publicly traded.

What exchange does DBV Technologies S.A. - American Depositary Shares trade on?

DBV Technologies S.A. - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for DBV Technologies S.A. - American Depositary Shares?

The ticker symbol for DBV Technologies S.A. - American Depositary Shares is DBVT on the Nasdaq Stock Market

What is the current price of DBV Technologies S.A. - American Depositary Shares?

The current price of DBV Technologies S.A. - American Depositary Shares is 19.09

When was DBV Technologies S.A. - American Depositary Shares last traded?

The last trade of DBV Technologies S.A. - American Depositary Shares was at 03/20/26 04:15 PM ET

What is the market capitalization of DBV Technologies S.A. - American Depositary Shares?

The market capitalization of DBV Technologies S.A. - American Depositary Shares is 1.05B

How many shares of DBV Technologies S.A. - American Depositary Shares are outstanding?

DBV Technologies S.A. - American Depositary Shares has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.